Zimmer Biomet promotes leaders. UBS sets USD 120 target for Zimmer Biomet stock

Published on 10/06/2026 at 15:40 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue reached USD 2.18 billion, up 4.80 percent year over year. Zimmer Biomet stock costs EUR 81.37 on October 6, 2026 after EUR 81.06, plus 0.38 percent.

Zimmer Biomet, US98956P1021, Illustration mit AI erstellt.

Zimmer Biomet (ISIN US98956P1021) announced leadership promotions effective October 1, 2026, while UBS reaffirmed a Buy rating and a USD 120.00 price target on August 6, 2026. As MarketScreener reports, Gary Campbell became President, Americas, Brian Hatcher took charge of several business groups, and Bradley Kessler became President, Americas - Robotics, Technology and Data.

Three leaders take new roles

The appointments are part of Zimmer Biomet's commercial restructuring, with Kevin Thornal leaving the company after a transition period ending September 30, 2026. The changes place robotics, technology, data and several procedure-focused businesses under newly promoted executives.

Second-quarter revenue rose 4.80 percent

Zimmer Biomet reported USD 2.18 billion in revenue for the second quarter of 2026, up 4.80 percent from the same quarter a year earlier, according to MarketBeat. Adjusted earnings per share reached USD 2.07, exceeding the USD 2.01 consensus by USD 0.06, while fiscal 2026 adjusted earnings-per-share guidance stood at USD 8.47 to USD 8.59.

Structured financial data show second-quarter 2026 operating cash flow of USD 447.8 million and revenue of USD 2.177 billion. The figures point to a business generating cash while management reshapes its commercial organization.

Next results are scheduled for November 4

Zimmer Biomet will publish its third-quarter 2026 results on November 4, 2026, with a conference call scheduled for 8:30 a.m. ET, according to StockTitan. The release is due at 6:30 a.m. ET, giving investors a defined checkpoint for the leadership changes and the 2026 outlook.

EUR 81.37 in afternoon trading

Zimmer Biomet stock was trading at EUR 81.37 at Lang & Schwarz on October 6, 2026 at 3:33 p.m. CEST, up 0.38 percent versus the prior close of EUR 81.06 on October 5, 2026. On the NYSE, the stock was last at USD 91.14 on October 6, 2026 at 9:39 a.m. ET, against a 52-week range of USD 79.12 to USD 106.88.

The further course of trading is shown by the continuously updated real-time quote of Zimmer Biomet stock.